Indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase 2 (TDO2) play pivotal roles in cancer viability and motility, and they facilitate tumor cells escaping the host immune system by catalyzing the initial step of the Kyn production. This evidence concerns the gene IDO1 and neoplasm.